In particular, NfL has served as an important biomarker for many neurodegenerative diseases such as multiple sclerosis (MS), Alzheimer’s disease (AD), and Parkinson’s disease (PD)4–7. The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.